ABI
SYK icon

Adamant Biomedical Investments’s Stryker SYK Stock Holding History

Adamant Biomedical Investments’s Portfolio SYK Stock Details SYK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$3.92M Sell
41,500
-16,000
-28% -$1.42M 0.94% 41
2014
Q3 		$4.64M Buy
+57,500
New +$4.73M 1.16% 32

Other funds holding SYK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
GT
Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
YAM
Yacktman Asset Management Austin, Texas $7.5B AUM 22.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Adamant Biomedical Investments's SYK Position: Q4 2014 in Review

Adamant Biomedical Investments reduced its Stryker (SYK) stake by 28% in Q4 2014, selling an estimated $1.42M and leaving 41,500 shares worth $3.92M. The position accounts for 0.94% of the portfolio, ranked #41.

Adamant Biomedical Investments first reported a position in SYK in Q3 2014 and has held it in 2 quarters since. The position peaked at $4.64M in Q3 2014. 887 funds tracked by Wall St. Rank hold SYK as of Q4 2014.

  • Adamant Biomedical Investments held 41,500 shares of Stryker worth $3.92M as of Q4 2014.
  • Adamant Biomedical Investments sold 16,000 Stryker shares in Q4 2014, an estimated $1.42M.
  • Stryker made up 0.94% of Adamant Biomedical Investments's portfolio in Q4 2014, its #41 holding.
  • Adamant Biomedical Investments first reported a position in Stryker in Q3 2014 and has held it in 2 quarters since.
  • Adamant Biomedical Investments's Stryker position peaked at $4.64M in Q3 2014.
  • 887 funds tracked by Wall St. Rank held Stryker as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.